-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIEF-AbCellera Announces Positive Top-Line Phase 2 Clinical Trial Results For ABCL635, Demonstrating Significant Reduction In Frequency And Severity Of Vasomotor Symptoms And A Favorable Tolerability Profile

Reuters·08/10/2026 11:15:05

Please log in to view news